Indaptus Therapeutics Files Q1 2025 10-Q
Ticker: INDP · Form: 10-Q · Filed: May 14, 2025 · CIK: 1857044
| Field | Detail |
|---|---|
| Company | Indaptus Therapeutics, INC. (INDP) |
| Form Type | 10-Q |
| Filed Date | May 14, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, quarterly-report, pharmaceuticals
TL;DR
Indaptus Therapeutics filed its Q1 2025 10-Q. All systems go.
AI Summary
Indaptus Therapeutics, Inc. filed its quarterly report for the period ending March 31, 2025. The company, formerly known as Intec Parent Inc., is incorporated in Delaware and operates in the pharmaceutical preparations sector. Its principal executive offices are located at 3 Columbus Circle, New York, NY.
Why It Matters
This filing provides investors with the latest financial and operational updates for Indaptus Therapeutics, Inc. as of the first quarter of 2025.
Risk Assessment
Risk Level: low — This filing is a standard quarterly report and does not contain immediate, high-impact news.
Key Players & Entities
- Indaptus Therapeutics, Inc. (company) — Filer of the 10-Q
- Intec Parent Inc. (company) — Former name of Indaptus Therapeutics, Inc.
- 20250331 (date) — End of reporting period
- 20250514 (date) — Filing date
- 3 Columbus Circle, New York, NY 10019 (location) — Business and mailing address
FAQ
What is the reporting period for this 10-Q filing?
The Conformed Period of Report is 20250331, indicating the filing covers the first quarter of 2025.
When was this 10-Q filed with the SEC?
The filing date (FILED AS OF DATE) is 20250514.
What was Indaptus Therapeutics, Inc. formerly known as?
The company was formerly known as Intec Parent Inc., with a date of name change on 20210414.
What is the Standard Industrial Classification code for Indaptus Therapeutics, Inc.?
The SIC code is 2834, which corresponds to Pharmaceutical Preparations.
Where are Indaptus Therapeutics, Inc.'s principal business offices located?
The business address is 3 Columbus Circle, 15th Floor, New York, NY 10019.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 14, 2025 regarding Indaptus Therapeutics, Inc. (INDP).